Affinity purification of influenza virus ribonucleoprotein complexes from the chromatin of infected cells.
Like all negative-strand RNA viruses, the genome of influenza viruses is packaged in the form of viral ribonucleoprotein complexes (vRNP), in which the single-stranded genome is encapsidated by the nucleoprotein (NP), and associated with the trimeric polymerase complex consisting of the PA, PB1, and PB2 subunits. However, in contrast to most RNA viruses, influenza viruses perform viral RNA synthesis in the nuclei of infected cells. Interestingly, viral mRNA synthesis uses cellular pre-mRNAs as primers, and it has been proposed that this process takes place on chromatin. Interactions between the viral polymerase and the host RNA polymerase II, as well as between NP and host nucleosomes have also been characterized. Recently, the generation of recombinant influenza viruses encoding a One-Strep-Tag genetically fused to the C-terminus of the PB2 subunit of the viral polymerase (rWSN-PB2-Strep) has been described. These recombinant viruses allow the purification of PB2-containing complexes, including vRNPs, from infected cells. To obtain purified vRNPs, cell cultures are infected, and vRNPs are affinity purified from lysates derived from these cells. However, the lysis procedures used to date have been based on one-step detergent lysis, which, despite the presence of a general nuclease, often extract chromatin-bound material only inefficiently. Our preliminary work suggested that a large portion of nuclear vRNPs were not extracted during traditional cell lysis, and therefore could not be affinity purified. To increase this extraction efficiency, and to separate chromatin-bound from non-chromatin-bound nuclear vRNPs, we adapted a step-wise subcellular extraction protocol to influenza virus-infected cells. Briefly, this procedure first separates the nuclei from the cell and then extracts soluble nuclear proteins (here termed the "nucleoplasmic" fraction). The remaining insoluble nuclear material is then digested with Benzonase, an unspecific DNA/RNA nuclease, followed by two salt extraction steps: first using 150 mM NaCl (termed "ch150"), then 500 mM NaCl ("ch500") (Fig. 1). These salt extraction steps were chosen based on our observation that 500 mM NaCl was sufficient to solubilize over 85% of nuclear vRNPs yet still allow binding of tagged vRNPs to the affinity matrix. After subcellular fractionation of infected cells, it is possible to affinity purify PB2-tagged vRNPs from each individual fraction and analyze their protein and RNA components using Western Blot and primer extension, respectively. Recently, we utilized this method to discover that vRNP export complexes form during late points after infection on the chromatin fraction extracted with 500 mM NaCl (ch500).
Department of Virology, Universitätsklinikum Freiburg. geoffrey.chase@uniklinik-freiburg.de
Geoffrey P
GP
Chase
Martin
M
Schwemmle
D015153:Blotting, Western / Q000379:methods*; D002843:Chromatin / Q000737:chemistry* / Q000821:virology*; D006367:HeLa Cells; D006801:Humans; D007251:Influenza, Human / Q000821:virology; D009975:Orthomyxoviridae / Q000737:chemistry*; D012367:RNA, Viral / Q000737:chemistry; D012261:Ribonucleoproteins / Q000737:chemistry / Q000302:isolation & purification*; D016622:Silver Staining / Q000379:methods; D013347:Subcellular Fractions / Q000737:chemistry / Q000821:virology; D014764:Viral Proteins / Q000737:chemistry / Q000302:isolation & purification*
D002843:Chromatin; C502893:PB2 protein, influenza virus; D012367:RNA, Viral; D012261:Ribonucleoproteins; D014764:Viral Proteins